| 【Company Research】CSPC Pharmaceutical (1093 HK) – Oncology portfolio to be a major growth driver |
| 【Company Research】Ascentage Pharma (6855 HK) – Pipeline in smooth progress; First NDA filing this year |
| 【Company Research】China Longyuan (916 HK) – Results slight beat; accelerate overseas expansion |
| 【Sector Research】China Banking Sector – 4Q19 results wrap – steady FY19 but challenging FY20 |
| 【Company Research】Hope Education (1765 HK) – Strong FY19 results |
| 【Company Research】Zoomlion Heavy Industry - A (000157 CH) – Dividend cut a surprise; Positive on the recovery story |
| 【Company Research】Zoomlion Heavy Industry - H (1157 HK) – Dividend cut a surprise; Positive on the recovery story |
| 【Company Research】Shimao (813 HK) – Expansion through M&A |
| 【Company Research】Weichai Power-A (000338 CH) – Correction offers buying opportunity; Diversification strategy on track |
| 【Company Research】Weichai Power-H (2338 HK) – Correction offers buying opportunity; Diversification strategy on track |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
